drug,indication,company,pdufa_date,fda_date_no_pdufa,source_url
---,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**Paxalisib (PNOC022)** [View Clinical Trial Data](javascript:;),,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**Roflumilast Cream (ARQ-151) - (INTEGUMENT-1 and INTEGUMENT-2)**,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**NurOwn** [View Clinical Trial Data](javascript:;),,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**SULANDA (surufatinib)**,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**HMPL-523 - (ESLIM-01)** BTD,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**Sovleplenib - (ESLIM-02)**,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**HMPL-306 - (RAPHAEL)**,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**RYONCIL (remestemcel-L) - (MSB-GVHD001)**,,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**Tumor Treating Fields (TTFields) - (LUNAR)** [View Clinical Trial Data](javascript:;),,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
**Tumor Treating Fields (TTFields) - (LUNAR)** [View Clinical Trial Data](javascript:;),,,,,https://www.biopharmcatalyst.com/calendars/fda-calendar
